Want to see AU:AHC full AI Analyst Report?
Austco Healthcare Limited (AHC) AI Stock Analysis
Top Page
Austco Healthcare Limited
(ASX:AHC)
The score is primarily driven by solid fundamentals—strong growth, improving net profitability, and a very low-debt balance sheet—partly offset by margin volatility and uneven cash flow consistency. Technical indicators are neutral-to-mixed (below the 200-day with a negative MACD), while valuation looks supportive with a low P/E.
Austco Healthcare Limited (AHC) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 104.93M
- Dividend Yield
- ―
- Average Volume (3M)
- 213.92K
- Price to Earnings (P/E)
- 11.6
- Beta (1Y)
- 0.69
- Revenue Growth
- 15.77%
- EPS Growth
- 48.47%
- Country
- Australia
- Employees
- 102
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Austco Healthcare Limited Business Overview & Revenue Model
Company Description
Austco Healthcare Limited, through its subsidiaries, operates as a global entity focused on the development, production, and comprehensive servicing of advanced healthcare and electronic communication systems. The company's market reach extends acros...
Austco Healthcare Limited Financial Statement Overview
Summary
Strong revenue acceleration into 2026 and improved net profitability, supported by a conservative, low-leverage balance sheet and healthy ROE. Offsetting factors are sharp 2026 gross margin compression and weaker free cash flow growth/coverage consistency despite positive FCF.
Income Statement
78PositiveBalance Sheet
86Very PositiveCash Flow
62Positive| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.24M | 94.24M | 81.41M | 58.15M | 41.98M | 35.88M |
| Gross Profit | 20.96M | 20.96M | 42.37M | 30.67M | 6.68M | 18.85M |
| EBITDA | 14.73M | 14.80M | 13.46M | 8.11M | 3.60M | 3.73M |
| Net Income | 9.01M | 9.01M | 5.93M | 7.08M | 2.26M | 2.33M |
Balance Sheet | ||||||
| Total Assets | 88.50M | 88.50M | 91.07M | 68.70M | 37.85M | 34.03M |
| Cash, Cash Equivalents and Short-Term Investments | 16.28M | 16.28M | 14.48M | 13.56M | 4.67M | 7.63M |
| Total Debt | 3.95M | 3.95M | 3.88M | 1.78M | 524.00K | 979.00K |
| Total Liabilities | 26.38M | 26.38M | 39.34M | 24.33M | 12.85M | 10.94M |
| Stockholders Equity | 62.12M | 62.12M | 51.73M | 44.38M | 25.00M | 23.09M |
Cash Flow | ||||||
| Free Cash Flow | 11.72M | 11.72M | 10.66M | 7.45M | -1.25M | 315.00K |
| Operating Cash Flow | 12.51M | 12.51M | 13.42M | 11.35M | 320.00K | 1.94M |
| Investing Cash Flow | -8.82M | -8.82M | -12.32M | -11.06M | -1.57M | -1.63M |
| Financing Cash Flow | -1.43M | -1.43M | -402.00K | 8.84M | -1.58M | -312.00K |
Austco Healthcare Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHC, the sentiment is Positive. The current price of 0.28 is above the 20-day moving average (MA) of 0.26, above the 50-day MA of 0.25, and below the 200-day MA of 0.29, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 63.96 is Neutral, neither overbought nor oversold. The STOCH value of 73.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:AHC.
Austco Healthcare Limited Peers Comparison
Overall Rating
AU:AHC70Outperform
AU:ALC63Neutral
AU:ONE48Neutral
AU:BMT45Neutral
AU:M7T43Neutral
AU:PGC39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | AUD 104.93M | 11.57 | 14.90% | ― | 15.77% | 48.47% | |
| 63Neutral | AUD 148.48M | 64.70 | 2.53% | ― | 26.61% | 41.67% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 48Neutral | AUD 109.10M | -6.40 | -203.69% | ― | -1.53% | 28.29% | |
| 45Neutral | AUD 21.26M | -1.14 | -58.13% | ― | 2.08% | -195.31% | |
| 43Neutral | AUD 61.10M | -6.84 | -24.29% | ― | -17.35% | -47.29% | |
| 39Underperform | AUD 256.57M | -16.14 | -5.34% | ― | 1.84% | -178.23% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:AHC | Austco Healthcare Limited | 0.28 | -0.15 | -35.63% | |
| AU:ONE | Oneview Healthcare PLC Chess Depository Interests repr 1 | 0.13 | -0.06 | -31.58% | |
| AU:M7T | Mach7 Technologies Ltd. | 0.26 | -0.04 | -13.33% | |
| AU:PGC | Paragon Care Limited | 0.15 | -0.17 | -51.56% | |
| AU:BMT | Beamtree Holdings Ltd | 0.07 | -0.15 | -67.27% | |
| AU:ALC | Alcidion Group Limited | 0.11 | 0.02 | 22.22% |
Austco Healthcare Limited Corporate Events
Austco grants new performance rights to managing director Clayton Astles
Austco Healthcare Limited has updated the market on a change in the securities held by managing director Clayton Astles. The disclosure details his direct and indirect holdings in ordinary shares and unlisted performance rights, reflecting his equity...
Austco Healthcare Shareholders Back All AGM Resolutions
Austco Healthcare Limited reported the results of its Annual General Meeting held on 19 October 2026, where shareholders strongly supported all resolutions put to the vote. Key items, including the adoption of the remuneration report, the re-election...
Austco Healthcare Delivers Record FY26 Results on Digital Health Growth
Austco Healthcare reported a record financial year in FY26, delivering revenue of $94.2 million, up 15.8%, and EBITDA growth of 14%, while integrating three acquired businesses. Software and maintenance revenue rose 19% to $11.4 million, lifting its...
Austco Healthcare Grants New Performance Rights and Seeks Shareholder Approval for Additional Equity Incentives
Austco Healthcare Limited has granted 2,548,312 Performance Rights under its Share Incentive Plan, covering a performance period from 1 July 2026 to 30 June 2029. The rights will vest based on a mix of earnings per share growth targets and indexed to...
Austco Healthcare Issues New Unquoted Performance Rights Under Incentive Scheme
Austco Healthcare Limited has notified the market of the issue of 2,548,312 unquoted performance rights under its employee incentive scheme, effective 1 October 2026. These securities, which will not be quoted on the ASX, form part of Austco’s...
Austco Director Increases Shareholding After Performance Rights Vesting
Austco Healthcare Limited has disclosed a change in the holdings of director Clayton Astles following the vesting of performance rights under the company’s employee share scheme. Astles received 677,486 ordinary shares transferred from the Aust...
Austco Healthcare Issues 2.7 Million New Shares on Conversion of Unquoted Securities
Austco Healthcare Limited has notified the market that 2,730,877 ordinary fully paid shares have been issued following the exercise or conversion of previously unquoted equity securities. The issuance of these additional shares on 28 September 2026 i...
Austco Alters Employee Share Plan to Allow On-Market Share Acquisition via Trust
Austco Healthcare has amended its Employee Share Incentive Plan to allow shares to be acquired, including on-market, and transferred to eligible participants via a share trust administered by Computershare’s CPU Share Plans Pty Ltd. The board u...
Austco Healthcare lifts profit and pipeline as acquisition integration drives growth
Austco Healthcare reported another year of growth for the 2026 financial year, with revenue rising 16% to a record $94.2 million and statutory net profit after tax jumping 52% to $9.0 million, supported by margin improvement and the full-year contrib...
Austco Healthcare to Hold Fully Virtual AGM in October 2026
Austco Healthcare Limited has called its Annual General Meeting for 19 October 2026, opting to conduct the event entirely online in line with legislative changes that permit virtual shareholder meetings. Using the Computershare platform, shareholders...
Austco Healthcare Delivers Record Revenue and Margin Gains in FY26
Austco Healthcare reported record FY26 customer revenue of $94.2 million, up 16% year on year, with EBITDA rising 14% to $14.9 million and NPAT surging 52% to $9.0 million, supported by a $51.2 million pipeline of unfilled contracted revenue. Perform...
Austco Healthcare Profit Jumps 52% on Strong Revenue Growth
Austco Healthcare Limited reported a 15.8% rise in revenue to $94.2 million for the year ended 30 June 2026, with EBITDA up 14.0% to $14.8 million and EBIT rising 7.0% to $10.9 million. Net profit after tax surged 51.8% to $9.0 million, supported by...
Austco Healthcare strengthens South Australian presence with MCS acquisition
Austco Healthcare Limited has completed the acquisition of Medical Communications Systems, its long-standing certified nurse call reseller in South Australia, bringing the reseller in-house after a relationship dating back to 2011. MCS, which has 12...
Austco Healthcare buys South Australian reseller in earnings-accretive deal
Austco Healthcare has agreed to acquire 100% of Medical Communications Systems, its long-standing certified nurse call reseller in South Australia, bringing the operation in-house. The deal continues Austco’s reseller acquisition strategy and i...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 17, 2026